Rinderon and malignant neoplasm progression Patient Reports February 11, 2012

Rinderon Side Effects Report #5237930-7
Rinderon side effect was reported by a Physician from JAPAN on Dec 27, 2006. Male patient, 53 years of age, was diagnosed with metastases to liver, metastases to lymph nodes, metastases to retroperitoneum, pancreatic carcinoma and was treated with Rinderon. After drug was administered, patient experienced the following side effects: cachexia, disseminated intravascular coagulation, malignant neoplasm progression. Rinderon dosage: 1 MG; QD; PO. During the same period patient was treated with OXYCONTIN, NOVAMIN, MAGNESIUM OXIDE, HYPEN, LOXONIN. Patient died on 03/01/2006.